Pharmaceuticals

Global Antibody Discovery Market Set for Strong Expansion, Reaching $15.79 Billion With 10.1% CAGR by 2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antibody discovery market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Antibody Discovery Market between 2026 and 2030?

The antibody discovery market has experienced robust expansion over recent years. It is projected to expand from $9.78 billion in 2025 to $10.75 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.8%. This historical increase is linked to several factors, including heightened R&D investments within antibody discovery, a growing incidence of infectious and chronic diseases, innovations in hybridoma technology, governmental support for biotechnology research, and partnerships between academic bodies and pharmaceutical companies.

The antibody discovery market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $15.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This projected growth is driven by several factors, including the increasing demand for personalized medicine, the integration of AI and ML into drug discovery processes, the expanding biologics market, the adoption of high-throughput screening platforms, and a heightened emphasis on immunotherapy and targeted therapies. Key trends expected during this period encompass advancements in high-throughput screening techniques, further developments in monoclonal antibodies, the emergence of personalized antibody therapeutics, the creation of multi-specific antibodies, and innovations in synthetic antibody engineering.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Antibody Discovery Market?

The increasing demand for precision therapeutics is anticipated to drive the expansion of the antibody discovery market moving forward. Precision therapeutics, also recognized as personalized therapeutics, involves adapting medical treatment strategies and interventions to align with the unique characteristics of each patient. Antibody discovery plays a crucial role in precision therapeutics by enabling the creation of targeted therapies, such as monoclonal antibodies, which are designed to interact specifically and precisely with disease-related molecules or cells for more effective and individualized patient care. For example, in March 2024, IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, stated that global spending on cell and gene therapies soared to $5.9 billion in 2023, marking a 38% increase from 2022. Therefore, the heightened necessity for precision therapeutics will propel the growth of the antibody discovery market.

How Is The Antibody Discovery Market Organized Into Various Segments?

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

What Trends Are Projected To Support The Growth Of The Antibody Discovery Market?

Major companies operating in the antibody discovery market are developing cutting-edge technologies, such as an AI-driven computational antibody drug discovery platform, to enhance the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational methods to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company focused on creating recombinant proteins from a specialized plant-based system, introduced an AI-powered antibody discovery platform. This innovative tool combines artificial intelligence, big data analytics, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to efficiently build comprehensive antibody libraries. This advanced system significantly accelerates the discovery of potential antibody drugs with remarkable speed.

Who Are The Core Companies Influencing Trends In The Antibody Discovery Market?

Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Which Regions Are Projected To Dominate The Antibody Discovery Market In The Coming Years?

North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antibody Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

Browse Through More Reports Similar to the Global Antibody Discovery Market 2026, By The Business Research Company

Antibody Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Research Antibodie And Reagent Market Report 2026

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Next Generation Antibody Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795